You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR FERRLECIT

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for FERRLECIT

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00223938 ↗	Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.	Terminated	Sanofi	Phase 4	2003-12-30	This is a phase 4 clinical investigation of the efficacy and safety of Ferrlecit in the maintenance of iron stores and serum hemoglobin concentration in hemodialysis patients receiving Erythropoietin.
NCT00223938 ↗	Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.	Terminated	Watson Pharmaceuticals	Phase 4	2003-12-30	This is a phase 4 clinical investigation of the efficacy and safety of Ferrlecit in the maintenance of iron stores and serum hemoglobin concentration in hemodialysis patients receiving Erythropoietin.
NCT00223964 ↗	Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients	Completed	Watson Pharmaceuticals	Phase 4	2003-06-01	This was a multi-center study in iron-deficient pediatric hemodialysis patients, whose legal guardian had provided signed informed consent and satisfied the inclusion and exclusion criteria.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for FERRLECIT

Condition Name

Chart
Table

Condition Name for FERRLECIT
Intervention	Trials
Anemia	6
Iron Deficiency Anemia	3
Kidney Failure, Chronic	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for FERRLECIT
Intervention	Trials
Anemia	7
Anemia, Iron-Deficiency	7
Renal Insufficiency	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for FERRLECIT

Trials by Country

Map
Table

Trials by Country for FERRLECIT
Location	Trials
United States	94
Poland	2
Mexico	2
Israel	2
Russian Federation	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for FERRLECIT
Location	Trials
California	7
New York	6
Texas	5
Missouri	5
Massachusetts	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for FERRLECIT

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for FERRLECIT
Clinical Trial Phase	Trials
Phase 4	10
Phase 3	1
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for FERRLECIT
Clinical Trial Phase	Trials
Completed	8
Recruiting	3
Withdrawn	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for FERRLECIT

Sponsor Name

Chart
Table

Sponsor Name for FERRLECIT
Sponsor	Trials
Watson Pharmaceuticals	7
University of Louisville	2
Rambam Health Care Campus	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for FERRLECIT
Sponsor	Trials
Other	12
Industry	8
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.